Advertisement

Topics

Companies Related to "Keytruda Immunotherapy Appears Active Treatment Liver Cancer" [Most Relevant Company Matches] - Page: 3 RSS

05:02 EST 21st February 2019 | BioPortfolio

Here are the most relevant search results for "Keytruda Immunotherapy Appears Active Treatment Liver Cancer" found in our extensive corporate database of over 50,000 company records.

Showing "Keytruda Immunotherapy Appears Active Treatment Liver Cancer" Companies 51–75 of 6,000+

Relevant

Gritstone Oncology

Gritstone Oncology is a privately-held, next-generation personalized cancer immunotherapy company. Gritstone brings together distinguished scientific founders, an experienced and diverse management team, a seasoned and successful board of directors, and deep financial backing to tackle fundamental challenges at the intersection of cancer genomics, immunolo...


BryoLogyx

BryoLogyx is developing a new class of drugs to enhance the response rates and treatment durability of cancer immunotherapies and anti-HIV agents. The company’s initial focus is on cancer, where it capitalizing on two recent scientific advances: the discovery that a complex natural product, bryostatin, stimulates tumor antigen production to amplify the ...

Northwest Biotherapeutics

Northwest Biotherapeutics (NWBT) is a biotechnology company focused on the clinical development of autologous immunotherapy products for cancer. Our technology platform, DCVax®, uses a patient’s own dendritic cells, the starter engine of the immune system, which are loaded with tumor proteins or antigens. Injection of these cells back into the patient initiates a potent immune response against ...


Jennerex Biotherapeutics, Inc.

Jennerex Biotherapeutics, Inc. is a clinical-stage biotechnology company focused on the development and commercialization of groundbreaking oncolytic immunotherapies for patients with life-threatening cancers. The company’s lead product candidate, Pexa-Vec (JX-594), is in mid-stage clinical development for the treatment of advanced primary liver cancer, ...

iQur Ltd

iQur® is a specialty pharmaceutical company at the forefront of international breakthroughs in the detection, treatment and monitoring of Hepatitis C and other liver diseases.iQur exists to provide clinicians with a comprehensive, 24–48 hour service for genotyping, qualitation and quantification of both the Hepatitis C (HCV) and Hepatitis B (HBV) viruses.Founded in 2003 by liver disease special...

Morphocell Technologies Inc.

Morphocell Technologies Inc. is a regenerative medicine company focused on the development and commercialization of stem cell therapies and engineered tissues targeting liver disease. Founded in April 2018, Morphocell Technologies aims at bringing to market the first effective treatment for acute, chronic and acute-on-chronic liver failure. www.morphocell.com ...

Vanteres

Vanteres is an innovative biotech company committed to the science-based development of lipid nutraceuticals for improving human health. Vanteres is leveraging its biomedical research expertise to develop actively transported lysophospholipids (ATLs) for a wide range of disease states. The company’s lead ATL is a lysophosphatidylcholine containing ess...

United Allergy Services

United Allergy Services™ (UAS) brings effective and convenient allergy testing and immunotherapy to primary care physicians; pulmonologists; ENT physicians; pediatricians; internal medicine physicians; and healthcare systems that treat the vast majority of patients with seasonal and perennial allergies. UAS’ complete service line features ...

Kanzius Cancer Research Foundation

The Kanzius Cancer Research Foundation is a 501(c)(3) non-profit organization with a mission to create national and global awareness of the potentials of the Kanzius Noninvasive Radiowave Cancer Treatment, and to help accelerate the speed at which this research progresses to human trials. The goal of KCRF is to raise money to support ongoing research grants. Pancreatic, liver and colorectal cance...

Onyx Pharmaceuticals, Inc.

Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer. The company, in collaboration with Bayer HealthCare Pharmaceuticals, Inc., is developing and marketing Nexavar® (sorafenib) tablets, a small molecule drug that is currently approved for the treatment of liver cancer and advanced kidney cancer. Additionally, Nexavar is being investigat...

Celldex therapeutics

Celldex is a biotechnology company focused on the discovery, development and commercialization of novel immunotherapeutics including human monoclonal antibodies for the treatment of cancer, infectious diseases, and immune system disorders. We are advancing a pipeline of clinical and pre-clinical product candidates.Our proprietary core technology utilizes human monoclonal antibodies to directly tar...

Gibson Oncology, LLC

Gibson is a private oncology drug development company dedicated to bringing its novel, cost-effective, and very well-tolerated Indeno anti-cancer treatments to market. Gibson intends to develop these novel anti-cancer drugs in advanced-stage cancer patients as single agent and in combination treatments with both immunotherapy and targeted therapies.

Cromwell Hospital

The Cromwell Hospital in London provides healthcare facilities for UK and overseas patients. Major specialities include cancer treatment, liver disease and transplant, neurosurgery, spinal surgery, heart surgery, gamma knife surgery (radiosurgery), paediatric care, craniofacial surgery and urology.

Autolus Therapeutics Limited

Autolus is a clinical-stage biopharmaceutical company developing next-generation, programmed T cell therapies for the treatment of cancer. Using a broad suite of proprietary and modular T cell programming technologies, the company is engineering precisely targeted, controlled and highly active T cell therapies that are designed to better recognise cancer c...

Endocare

Endocare's mission is to radically improve patients lives through ground breaking core technology. Endocare promotes its cryotherapy technology to urologists for the treatment of prostate cancer and renal tumors, however, we are expanding our focus across a number of surgical markets, including the ablation of tumors in the lung and liver, as well as pain management.

Virginia Cancer Specialists

For more than 30 years, Virginia Cancer Specialists (VCS) has contributed to the campaign against cancer and diseases of the blood. VCS has nine locations throughout Northern Virginia staffed by highly-skilled physicians, each promising exceptional care. This care consists of advancements in early detection, treatment, and clinical trials. Offering emotional as well as physical support, VCS is hom...

Oncolab Incorporated

An Innovative Aid in Early Cancer Diagnosis and Follow up Oncolab provides the FDA approved AMAS blood test, helping health care professionals to diagnose cancer, and to follow up during treatment. In studies of more than 8,000 patients, the AMAS® Test was found to be 95% accurate and unique for its diverse use as a diagnostic tool regarding all non-terminal cancers. In some cases, the AMAS® t...

Nativis Inc.

Founded in 2002 and headquartered in Seattle, WA, Nativis is a clinical-stage bio-electronics company. Nativis has invented and patented a groundbreaking technology that utilizes precisely targeted, ultra-low radio frequency energy (ulRFE) to specifically regulate metabolic pathways on the molecular and genetic levels – without chemicals, radiation or...

Genetronics Biomedical

Genetronics' most advanced effort involves treating those with head and neck cancer, a particularly devastating cancer that can severely limit the ability of these patients to see, taste, hear, talk, breathe, or swallow. Genetronics received approval from the U.S. Food and Drug Administration and initiated Phase II multi-center clinical trials at nine sites in the U.S. The trials test the effectiv...

AlphaNet, Inc.

Alpha-1 Antitrypsin Deficiency is one of North America’s most prevalent, potentially lethal hereditary disorders. Discovered in 1963, Alpha-1 can cause life-threatening lung and/or liver disease. It is a leading genetic killer of adults in North America and a leading cause of liver transplants in children. It is estimated that between 10,000 and 15,000 ...

TapImmune Inc.

TapImmune Inc. is an immunotherapy company specializing in the development of innovative vaccine technologies for the treatment of cancer and infectious disease. The Company’s vaccine compositions, peptide or nucleic acid-based, comprise one or multiple naturally processed epitopes (NPEs) designed to comprehensively stimulate a patients’ killer T...

Biothera Pharmaceuticals, Inc.

Biothera is a privately held biotechnology company developing Imprime PGG, a clinical stage immunotherapy drug that modulates key immune cells to orchestrate a coordinated immune response to cancer that involves both the innate and adaptive immune system. Proof of concept has been established from single-arm and randomized phase 2 studies in non-small cell...

Cancer Treatment Research and Educational Institute

The non-profit Cancer Treatment Research and Educational Institute was founded in 1993 by Karel A. Dicke, M.D., Ph.D. for the purpose of research and education into new developments in diagnosis, prognosis and treatment of cancer.

Celsion

Founded in 1982, with a vision of using heat to kill cancer and treat other diseases, Celsion began trading publicly in 1985 under the name Cheung Laboratories, Inc. The early research focus of the Company was device oriented heat-based treatment systems. The Company was renamed Celsion Corporation and listed on the American Stock Exchange under the symbol CLN, in the mid 1990's. At that time, Cel...

Xenova

Xenova Group Limited, a fully-owned subsidiary of Celtic Pharma Development plc, is a UK-based biopharmaceutical company focused on the development of novel drugs to treat cancer and addiction with a secondary focus in immunotherapy. The Company has a broad pipeline of drug candidates in clinical development including a novel programme for the treatment of high-grade glioma, TransMIDTM. Details of...


More From BioPortfolio on "Keytruda Immunotherapy Appears Active Treatment Liver Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks